OC
TMO icon

Oakworth Capital’s Thermo Fisher Scientific TMO Stock Holding History

Oakworth Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$785K Sell
1,554
-554
-26% -$266K 0.04% 118
2026
Q1 		$1.04M Sell
2,108
-6
-0.3% -$3.26K 0.05% 89
2025
Q4 		$1.22M Buy
2,114
+12
+0.6% +$6.79K 0.07% 77
2025
Q3 		$1.02M Buy
2,102
+13
+0.6% +$6.05K 0.06% 86
2025
Q2 		$847K Sell
2,089
-311
-13% -$130K 0.05% 93
2025
Q1 		$1.19M Sell
2,400
-693
-22% -$375K 0.08% 65
2024
Q4 		$1.61M Buy
3,093
+262
+9% +$144K 0.11% 57
2024
Q3 		$1.75M Sell
2,831
-31
-1% -$18.4K 0.12% 54
2024
Q2 		$1.58M Buy
2,862
+158
+6% +$90.5K 0.12% 57
2024
Q1 		$1.57M Sell
2,704
-63
-2% -$35.4K 0.12% 56
2023
Q4 		$1.47M Buy
2,767
+23
+0.8% +$11.1K 0.12% 56
2023
Q3 		$1.39M Buy
2,744
+26
+1% +$13.9K 0.13% 54
2023
Q2 		$1.42M Sell
2,718
-301
-10% -$162K 0.12% 53
2023
Q1 		$1.74M Buy
3,019
+255
+9% +$144K 0.16% 44
2022
Q4 		$1.52M Sell
2,764
-33
-1% -$17.5K 0.15% 41
2022
Q3 		$1.42M Buy
2,797
+252
+10% +$141K 0.16% 45
2022
Q2 		$1.38M Hold
2,545
– – 0.14% 49
2022
Q1 		$1.5M Sell
2,545
-65
-2% -$37.3K 0.13% 53
2021
Q4 		$1.74M Buy
2,610
+235
+10% +$147K 0.15% 46
2021
Q3 		$1.36M Buy
2,375
+70
+3% +$38.4K 0.13% 52
2021
Q2 		$1.16M Buy
2,305
+36
+2% +$17K 0.12% 56
2021
Q1 		$1.04M Buy
2,269
+8
+0.4% +$3.82K 0.12% 62
2020
Q4 		$1.05M Sell
2,261
-10
-0.4% -$4.69K 0.14% 51
2020
Q3 		$1M Buy
2,271
+22
+1% +$9.09K 0.16% 51
2020
Q2 		$815K Buy
2,249
+22
+1% +$7.37K 0.15% 59
2020
Q1 		$631K Buy
2,227
+277
+14% +$87.3K 0.15% 61
2019
Q4 		$639K Buy
1,950
+288
+17% +$87.3K 0.11% 74
2019
Q3 		$484K Hold
1,662
– – 0.09% 79
2019
Q2 		$488K Buy
1,662
+157
+10% +$43.2K 0.09% 88
2019
Q1 		$412K Sell
1,505
-880
-37% -$219K 0.08% 104
2018
Q4 		$534K Buy
2,385
+909
+62% +$213K 0.12% 74
2018
Q3 		$360K Buy
1,476
+341
+30% +$78.4K 0.07% 113
2018
Q2 		$235K Buy
1,135
+10
+0.9% +$2.12K 0.05% 146
2018
Q1 		$237K Hold
1,125
– – 0.06% 141
2017
Q4 		$217K Sell
1,125
-20
-2% -$3.83K 0.05% 152
2017
Q3 		$214K Buy
1,145
+880
+332% +$159K 0.06% 152
2017
Q2 		$46K Hold
265
– – 0.01% 298
2017
Q1 		$41K Hold
265
– – 0.01% 299
2016
Q4 		$37K Hold
265
– – 0.01% 296
2016
Q3 		$42K Buy
265
+3
+1% +$462 0.01% 276
2016
Q2 		$40K Hold
262
– – 0.02% 273
2016
Q1 		$37K Buy
262
+28
+12% +$3.75K 0.01% 239
2015
Q4 		$33K Buy
234
+34
+17% +$4.54K 0.01% 230
2015
Q3 		$24K Hold
200
– – 0.01% 220
2015
Q2 		$28K Hold
200
– – 0.01% 210
2015
Q1 		$25K Hold
200
– – 0.01% 250
2014
Q4 		$25K Hold
200
– – 0.01% 244
2014
Q3 		$24K Hold
200
– – 0.01% 210
2014
Q2 		$24K Hold
200
– – 0.01% 213
2014
Q1 		$24K Hold
200
– – 0.02% 210
2013
Q4 		$22K Buy
+200
New +$19.9K 0.02% 197

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Oakworth Capital's TMO Position: Q2 2026 in Review

Oakworth Capital reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q2 2026, selling an estimated $266K and leaving 1,554 shares worth $785K. The position accounts for 0.04% of the portfolio, ranked #118.

Oakworth Capital first reported a position in TMO in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.75M in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Oakworth Capital held 1,554 shares of Thermo Fisher Scientific worth $785K as of Q2 2026.
  • Oakworth Capital sold 554 Thermo Fisher Scientific shares in Q2 2026, an estimated $266K.
  • Thermo Fisher Scientific made up 0.04% of Oakworth Capital's portfolio in Q2 2026, its #118 holding.
  • Oakworth Capital first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 51 quarters since.
  • Oakworth Capital's Thermo Fisher Scientific position peaked at $1.75M in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.